(Q40890707)

English

Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34(+) cells from patients with del(5q) myelodysplastic syndrome

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34(+) cells from patients with del(5q) myelodysplastic syndrome (English)

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

Uwe Platzbecker

6

object named as

Uwe Platzbecker

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

Hans Joachim Deeg

4

object named as

H Joachim Deeg

1 reference

Europe PubMed Central

24 September 2017

PMC publication ID

author name string

Christopher P Venner

1

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

Joanna Wegrzyn Woltosz

2

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

Thomas J Nevill

3

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

Gisela Caceres

5

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

Bart L Scott

7

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

Lubomir Sokol

8

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

Sandy Sung

9

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

Alan F List

10

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

Aly Karsan

11

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

publication date

28 August 2012

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

98

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

3

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

409-413

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion--the GFM experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

Report of an international working group to standardize response criteria for myelodysplastic syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

24 September 2017

Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

15 June 2018

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

19 August 2018

Persistent malignant stem cells in del(5q) myelodysplasia in remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

19 August 2018

Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3659949

19 August 2018

MicroRNA-146a disrupts hematopoietic differentiation and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/22929976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22929976

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2012.066068

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

24 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40890707&oldid=1909617225"